All Stories

  1. Nanoinformatics: Artificial Intelligence and Nanotechnology in the New Decade
  2. MS-275 Chemical Analogues Promote Hemoglobin Production and Erythroid Differentiation of K562 Cells
  3. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints
  4. Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
  5. Aqueous Solubility Enhancement for Bioassays of Insoluble Inhibitors and QSPR Analysis: A TNF-α Study
  6. Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening
  7. Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors
  8. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors
  9. Editorial: Towards Open Access for Cheminformatics
  10. Open-Source Chemoinformatics Software
  11. Open Source Chemoinformatics Software including KNIME Analytics Platform
  12. A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform
  13. Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening
  14. Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part II))
  15. Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs
  16. Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part I))
  17. Meet our Editorial Board Members
  18. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors
  19. Stability and binding effects of silver(I) complexes at lipoxygenase-1
  20. Editorial
  21. Antiproliferative novel isoxazoles: Modeling, virtual screening, synthesis, and bioactivity evaluation
  22. Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles
  23. Editorial
  24. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches
  25. Enalos KNIME nodes: Exploring corrosion inhibition of steel in acidic medium
  26. Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers
  27. Comparative study of the AT1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers
  28. Comparative Binding Effects of Aspirin and Anti-Inflammatory Cu Complex in the Active Site of LOX-1
  29. Molecular Modeling on Pyrimidine-Urea Inhibitors of TNF-α Production: An Integrated Approach Using a Combination of Molecular Docking, Classification Techniques, and 3D-QSAR CoMSIA
  30. Ligand and Structure Based Virtual Screening Strategies for Hit-Finding and Optimization of Hepatitis C Virus (HCV) Inhibitors
  31. Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks
  32. Functionalized 4-Hydroxy Coumarins: Novel Synthesis, Crystal Structure and DFT Calculations
  33. In Silico Exploration for Identifying Structure-Activity Relationship of MEK Inhibition and Oral Bioavailability for Isothiazole Derivatives
  34. Collaborative development of predictive toxicology applications
  35. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts
  36. A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs
  37. Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
  38. A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas
  39. Development and Evaluation of a QSPR Model for the Prediction of Diamagnetic Susceptibility
  40. Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure
  41. Design and Synthesis of Novel Quinolinone-3-aminoamides and Their α-Lipoic Acid Adducts as Antioxidant and Anti-inflammatory Agents
  42. Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening
  43. A Novel QSAR Model for Evaluating and Predicting the Inhibition Activity of Dipeptidyl Aspartyl Fluoromethylketones
  44. A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes
  45. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis
  46. A Novel RBF Neural Network Training Methodology to Predict Toxicity to Vibrio Fischeri
  47. A novel QSPR model for predicting θ (lower critical solution temperature) in polymer solutions using molecular descriptors
  48. Prediction of intrinsic viscosity in polymer–solvent combinations using a QSPR model
  49. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices
  50. Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques
  51. Prediction of toxicity using a novel RBF neural network training methodology
  52. Prediction of high weight polymers glass transition temperature using RBF neural networks
  53. Novel Short-Step Synthesis of Functionalized γ-Phenyl-β-hydroxybutenoates and Their Cyclization to 4-Hydroxycoumarins via the N-Hydroxybenzotriazole Methodology.
  54. Novel Short-Step Synthesis of Functionalized γ-Phenyl-β-hydroxybutenoates and their Cyclization to 4-Hydroxycoumarins via the N-Hydroxybenzotriazole Methodology
  55. Development of nonlinear quantitative structure-activity relationships using rbf networks and evolutionary computing
  56. Cyclisation of Novel Amino Oxo Esters to Tetramic Acids− Density Functional Theory Study of the Reaction Mechanism
  57. Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials